MLICM
XMTR icon

Metropolitan Life Insurance Company (MetLife)’s Xometry XMTR Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio XMTR Stock Details XMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,964
Closed -$33.2K – 2136
2024
Q1 		$33.2K Hold
1,964
– – ﹤0.01% 1609
2023
Q4 		$70.5K Sell
1,964
-274
-12% -$5.88K ﹤0.01% 1262
2023
Q3 		$38K Buy
2,238
+368
+20% +$6.96K ﹤0.01% 1555
2023
Q2 		$39.6K Hold
1,870
– – ﹤0.01% 1569
2023
Q1 		$28K Sell
1,870
-222
-11% -$5.84K ﹤0.01% 1719
2022
Q4 		$67.4K Hold
2,092
– – ﹤0.01% 1290
2022
Q3 		$119K Hold
2,092
– – 0.01% 924
2022
Q2 		$71K Buy
2,092
+449
+27% +$15.5K ﹤0.01% 1282
2022
Q1 		$60.4K Sell
1,643
-748
-31% -$34.2K ﹤0.01% 1484
2021
Q4 		$123K Hold
2,391
– – ﹤0.01% 2354
2021
Q3 		$138K Buy
+2,391
New +$166K ﹤0.01% 2334

Other funds holding XMTR

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ONPI
Owls Nest Partners IA Chadds Ford, Pennsylvania $286M AUM 16.4% 1-Year Est. Return
SC
Sylebra Capital Palo Alto, California $774M AUM 56.69% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s XMTR Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Xometry (XMTR) in Q2 2024, closing a stake of 1,964 shares — an estimated $33.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in XMTR in Q3 2021 and held it in 11 quarters. The position peaked at $138K in Q3 2021. 125 funds tracked by Wall St. Rank hold XMTR as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Xometry position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,964 Xometry shares in Q2 2024, an estimated $33.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Xometry in Q3 2021 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Xometry position peaked at $138K in Q3 2021.
  • 125 funds tracked by Wall St. Rank held Xometry as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.